USC researchers discover a natural hormone that could reverse the effects of inflammaging

Source Cryptopolitan

Researchers at USC’s Keck School of Medicine have discovered a natural hormone that could reverse the effects of Inflammaging. 

The USC team, led by surgery and immunology professor Fumito Ito, found in a new study that a hormone called “thymulin” could be the key to controlling inflammaging and slowing down biological aging.

Inflammaging is tied to several age-related diseases such as cancer, heart disease, metabolic conditions, and neurodegenerative disorders. The condition progressively worsens as people age. 

For such a life-threatening condition, scientists have been struggling to understand what fuels age-related inflammation and ways to restore immune functions affected by it. 

USC researchers identify thymulin as a key regulator of inflammation

In their study, the USC researchers found that thymulin output declines with age, and as it falls, the chances of inflammation rise as well, pointing to the hormone, produced by a small organ called the thymus behind the breastbone, as a key regulator of inflammaging. 

“This is the first evidence of a substance that is naturally produced in the thymus, declines with age, and has the power to reverse age-related inflammation,” said Professor Ito. 

The team made this finding by surgically linking an old mouse to a young one, a technique known as heterochronic parabiosis, where both mice shared the same blood circulation. 

The procedure increased the levels of thymulin in the older mouse, which saw an increase in their antitumor immune response and overall survival. 

“Together, these findings uncover a pathway linking aging, inflammation and cancer immunity, and suggest thymulin as a potential strategy to improve cancer immunotherapy in older individuals,” said Ito.

At the moment, the work sits in mice and lab dishes, and not in people. Ito’s team said thymulin could eventually be tested in clinical trials for cancer and other conditions. 

Next, they plan to study the role of thymulin in other chronic diseases and also explore whether the hormone influences how tumors form and spread.

Researchers make another major discovery in anti-aging

The USC team’s findings today are yet another major discovery in the ongoing battle against aging. 

Last week, another group of researchers at Revel Pharmaceuticals created an enzyme that strips advanced glycation end products (AGEs) off proteins in aged human tissue. For decades, scientists have viewed AGEs as irreversible.

The enzyme specifically targets Nε-carboxymethyl-lysine, or CML, which is the most abundant AGE. It oxidizes any CML modification and then restores the protein to its original lysine residue, Cryptopolitan reported. 

The smartest crypto minds already read our newsletter. Want in? Join them.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Japan, South Korea Stocks Rise in Early Trade; Samsung, SK Hynix Soar, SoftBank, Kioxia Track GainsTradingKey - Both the KOSPI and Nikkei 225 indexes opened higher, led by gains in Samsung Electronics and SK Hynix, with SoftBank and Kioxia following suit.During the Asian session on June 30, both Ja
Author  TradingKey
6 Month 30 Day Tue
TradingKey - Both the KOSPI and Nikkei 225 indexes opened higher, led by gains in Samsung Electronics and SK Hynix, with SoftBank and Kioxia following suit.During the Asian session on June 30, both Ja
placeholder
XRP Price Prediction for July 2026: Can Buyers Finally Break the Downtrend?XRP (XRP) price trades near $1.05, caught between a year-long downtrend and a sudden burst of buying.July has historically rewarded XRP holders. This year the month arrives with on-chain accumulation
Author  Beincrypto
6 Month 30 Day Tue
XRP (XRP) price trades near $1.05, caught between a year-long downtrend and a sudden burst of buying.July has historically rewarded XRP holders. This year the month arrives with on-chain accumulation
placeholder
What to Expect From Ethereum (ETH) in July 2026Ethereum (ETH) enters July 2026 trading near $1,570, close to multi-month lows, after recording its first run of three consecutive red quarterly candles in its history.On-chain data and price charts n
Author  Beincrypto
7 Month 01 Day Wed
Ethereum (ETH) enters July 2026 trading near $1,570, close to multi-month lows, after recording its first run of three consecutive red quarterly candles in its history.On-chain data and price charts n
placeholder
Intel Price Forecast: Nvidia Picked Xeon 6, Invested $5B, Yet Analysts Still Trail INTCIntel Corporation (NASDAQ: INTC) sits at $140.05, holding firm on the ascending trendline within the 2H timeframe. The RSI indicator is currently reading 55.21, positioning it as neutral-
Author  TradingKey
7 Month 02 Day Thu
Intel Corporation (NASDAQ: INTC) sits at $140.05, holding firm on the ascending trendline within the 2H timeframe. The RSI indicator is currently reading 55.21, positioning it as neutral-
placeholder
NVIDIA Price Forecast: Michael Burry Shorts NVDA, but Analysts See $299On July 1, NVIDIA (NASDAQ: NVDA) sits at $198.34, failing to break above the former support level that is now serving as resistance between $198 and $205 on the 2H chart's downward blue c
Author  TradingKey
7 Month 02 Day Thu
On July 1, NVIDIA (NASDAQ: NVDA) sits at $198.34, failing to break above the former support level that is now serving as resistance between $198 and $205 on the 2H chart's downward blue c
goTop
quote